InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the detailed record of transactions filed by Klausner Richard, Président Exécutif. Director active across 1 companies, notably Lyell Immunopharma, Inc.. In total, 2 reports have been published. Regulator: SEC (Form 4). The full history is free.
Declarations2 total
3,765,842 shares
Common Stock
SEC:0001209191-21-042798·
3,765,842 shares
Common Stock
SEC:0001209191-21-042798:0·
2 of 2 declarations
About Klausner Richard
Richard Klausner is the Executive Chairman of Lyell Immunopharma, Inc. He plays a key role in the strategic direction of the company, bringing his expertise in biotechnology and drug development. His role as a board member includes overseeing performance and evaluating initiatives aimed at enhancing innovation and research. He ensures that Lyell Immunopharma meets its performance and innovation objectives.
